Media coverage of portfolio companies and philanthropic activities
2010-08-12
OriGene Technologies Acquires Blue Heron Biotechnology, a Leading U.S. based Gene Synthesis Company
OriGene Technologies, Inc., a gene-centric life sciences company, announces the acquisition of Blue Heron Biotechnology, a pioneer in the gene synthesis business since 1999...
2010-08-10
Plastic Logic Moves On To Next Generation Product
Plastic Logic today announced it is revising its product strategy and plans to shift its focus to bring to market a second-generation ProReader plastic electronics-based product. The company said it has cancelled its QUE product, which it debuted at CES in January 2010 and planned to ship earlier this year....
2010-08-05
SBIR Funding Helps Advance RNA Detection Technology Development, Enables Personalized Medicine
With Phase I Grant funding provided by the National Cancer Institute SBIR Development Center, Advanced Cell Diagnostics (ACD) completed the development of its RNAscope™ technology and is currently developing cell- and tissue-based diagnostic tests for personalized medicine focusing on cancer....
2010-06-14
Stealth Peptides Inc. Completes Initial Phase I Clinical Trial Cohort with BendaviaTM, a Mitochondrial Targeted Therapy for Ischemia Reperfusion Injury
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative therapies, announced today that it concluded its initial Phase I clinical trial cohort of a first–in–humans study with Bendavia™, a compound that targets mitochondria to treat ischemia reperfusion injury. The Investigational New Drug (IND) application for Bendavia was approved by the U.S. Food and Drug Administration (FDA) during May 2010....
2010-06-14
BioScale Raises $25 Million for Commercialization and Manufacturing of Protein Analytics Technology Company Developing, Manufacturing and Marketing ViBE™ Systems to Enhance Development and Production of Biotherapeutics
BioScale Inc., a privately-held life science company that develops, manufactures and promotes a new generation of protein analytics technology, today announced that it has secured $25 million in its recent financing round...
2010-05-17
Stealth Peptides Inc. Announces FDA IND Approval for Conduct of Clinical Studies with Bendavia™, A Mitochondrial Targeted Therapy for Ischemia Reperfusion Injury
Stealth Peptides Inc.(Stealth), a privately held biopharmaceutical company developing innovative therapies, announced today that the U.S. Food and Drug Administration (FDA) approved its Investigational New Drug (IND) application for Bendavia™....
2010-04-08
Stealth Peptides Development Roundup
Stealth recently filed an investigational new drug (IND) application with the U.S. FDA for Bendavia™ , a compound that targets the mitochondria to treat ischemia reperfusion injury....
2010-02-23
CellCentric Licenses Novel Epigenetic Discovery Programme to Takeda
From its broad portfolio of novel targets in epigenetics, CellCentric has out-licensed exclusively the development and commercialisation of an important programme focused on cancer....
2010-02-16
CellCentric heads new collaboration with Sigma-Aldrich, The Automation Partnership and leading epigenetic researchers
The University of Cambridge, UCL (University College London), CellCentric, Sigma-Aldrich and The Automation Partnership embark on a collaboration to define markers of epigenetic reprogramming, supported by £1.1m from the UK Government’s Technology Strategy Board....
2010-02-05
Investors Retain Serica's Ortho Tech In New Co. After Sale To Allergan
Backers including Morningside Technology Ventures, Ivy Capital Partners and Prism VentureWorks will get back "much more" than the $24 million invested into the company. The firms have also launched a new company based on the technology they retained after the sale...
2010-02-04
Novel Tissue Regeneration Technologies Added to Allergan’s Breast Aesthetic and Reconstructive Surgery Portfolio / New Company Created from Orthopedic and Veterinary Assets
Morningside Technology Ventures, Prism VentureWorks, and Ivy Capital Partners are pleased to announce the acquisition of their portfolio company, Serica Technologies, Inc. by Allergan, Inc. Serica is a growth-stage medical device company focused on the development of biodegradable silk-based scaffolds for use in tissue regeneration in numerous therapeutic areas...
2010-01-19
Morningside and Can Fite BioPharma to Establish a Joint Venture to Develop and Commercialize Can-Fite¡¦s CF102 Drug for the Treatment of Liver Diseases
a biopharmaceutical company, announced today the signing of a memorandum of understanding (MOU), with the Hong Kong based Morningside Asia Venture (HK) Limited. According to this MOU, Can-Fite and Morningside will establish a JV, which will receive an exclusive license to the Intellectual Property relating to CF102 in China, Hong Kong, Macau and Taiwan, and will be responsible for the clinical development of CF102 for these markets.....
2009-11-11
BioVex's $70M Series F to Fund Pivotal OncoVex Melanoma Trial
The terms "cancer vaccine" and "gene therapy" don't tend to inspire investor confidence, given the history of high-profile failures in both fields. Nor does "melanoma," for that matter.....
2009-11-10
BioVex Completes $70 Million Financing to Conclude Pivotal Study With Its Pioneering Cancer Treatment, OncoVEX (GM-CSF)
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March....
2009-11-02
BIOVEX ANNOUNCES PUBLICATION OF PHASE 2 MELANOMA RESULTS WITH ONCOVEXGM-CSF IN THE JOURNAL OF CLINICAL ONCOLOGY
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the data from its completed Phase 2 clinical study of OncoVEXGM-CSF for the treatment of advanced melanoma has been published in the Journal of Clinical Oncology (JCO)...
2009-09-20
ACD Completes the Second Closing of Series a Financing and Initiates Services for Biomarker Validation and Companion Diagnostic Development
Advanced Cell Diagnostics, Inc. (ACD), announced that it has completed the second closing of its Series A equity financing from Morningside Ventures, bringing the total capital raised in this round to $5.4 million...
2009-09-09
OriGene Launches 5,000 Purified Human Proteins from HEK293 Cells
OriGene Technologies, Inc. announces the release of 5,000 purified human proteins, representing the most comprehensive offering of human cell-produced human proteins...
2009-05-06
CellCentric has expanded its agreement with Shanghai-based HD Biosciences to move epigenetic targets from screening into drug discovery
CellCentric, the biotechnology company unlocking epigenetic control mechanisms, is pleased to announce that it has signed an enlarged agreement with HD Biosciences (HDB), a company specialising in drug discovery contract research, in order to further build CellCentric’s portfolio of drug discovery programmes...
2009-04-29
Inimex Pharmaceuticals clinic roundup
Inimex Pharmaceuticals Inc., of Vancouver, British Columbia, said it began administering IMX942, an innate defense regulator, in healthy volunteers in a Phase I study. The goal is to demonstrate safety and biological effects in humans..
2009-03-11
Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair
Serica Technologies, Inc., a growth-stage medical device company developing silk-based biomaterial platforms for tissue regeneration, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SeriScaffold(TM) silk-based, long term bioresorbable scaffold technology...
2009-03-07
Genocea Biosciences Closes $23 Million Series a Financing, Names Vaccine Veteran Staph Leavenworth Bakali CEO
Genocea Biosciences, a vaccine discovery and development company, announced that it has raised a $23 million Series A financing led by SR One, the corporate venture arm of GlaxoSmithKline [GSK]. New investors Auriga Partners, Cycad Group, and Alexandria Real Estate Equities also participated in the financing and were joined by returning founding investors Lux Capital Management, Polaris Venture Partners and Morningside Ventures...
2009-02-27
Zinio Announces Partnership with Plastic Logic to Supply Digital Magazine Content for Upcoming eReader Device
Zinio (www.zinio.com) announced an agreement with Plastic Logic to enable Plastic Logic to have access to its massive, global stable of digital magazines and other digital content. With this agreement, Zinio will provide all members of its broad network (including publishers and advertisers) a new channel of content distribution, sales and engagement...
2009-02-26
Plastic Logic Selects LibreDigital to Deliver Digital Publishing Content to New eReader
At the O Reilly Tools of Change for Publishing Conference, LibreDigital, Inc., announced that Plastic Logic has selected LibreDigital ePublishing technology to serve published content to the new Plastic Logic Reader. As part of the agreement, major publishers of newspapers, magazines and other media can deliver their content to the new eReader giving users an experience mirroring and extending traditional print editions....
2009-02-25
OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China
OriGene Technologies, Inc. ("OriGene") announced it has raised an additional $6.5 million in a private equity financing. With this financing, OriGene completed the acquisition of the assets of privately held Shenzhen P & A Biotech, a manufacturer and provider of monoclonal antibodies (mAb) to the research community...
2009-02-24
Pfizer Inc announced today that Pfizer awarded HD Biosciences its “2008 Top Research Service Partner Award”
HD Biosciences Co., Ltd. (HDB), a Shanghai-based biotechnology company specializing in high value drug discovery contract research services, and Pfizer Inc announced today that Pfizer awarded HD Biosciences its “2008 Top Research Service Partner Award”...
2009-02-19
Lux Ventures II: Genocea Biosciences Closes $23 Million Series A Financing
Genocea Biosciences, a vaccine discovery and development company, today announced that it has raised a $23 million Series A financing led by SR One, the corporate venture arm of GlaxoSmithKline [GSK]. New investors Auriga Partners, Cycad Group, and Alexandria Real Estate Equities also participated in the financing and were joined by returning founding investors Lux Capital Management, Polaris Venture Partners and Morningside Ventures...
2009-02-16
Plastic Logic Reader - a Kindle Killer
The new Plastic Logic EBook reader will be available next year but already experts are calling it as oeKindle killer for the many features it boasts compared to Amazons Kindle 2.Amazon Kindle 2 was launched last week with fanfare, but already it seems to have competition from Plastic Logic.The Plastic Logic reader was on display last week at oeTools of Change for Publishing Conference in New York.A demonstration of the reader is shown in the video here...
2009-02-11
OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China
("OriGene") today announced it has raised an additional $6.5 million in a private equity financing. With this financing, OriGene completed the acquisition of the assets of privately held Shenzhen P&A Biotech...
2009-02-06
MedMira and Morningside Announce Final Approval of Private Placement
MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, and Morningside Venture (IV) Investments Limited ("Morningside"), part of Morningside Asia, a Hong Kong-based institutional private equity and venture capital group, jointly announced today the final approval of $250US,000....
2009-02-04
CellCentric Expands its Leadership Team
Newly appointed President and CSO, David Knowles, and Director of Discovery Research, Neil Pegg will drive CellCentric’s epigenetic target programmes into lead optimisation and beyond...
2009-01-28
MedMira Moves Forward with Outsourced Manufacturing Strategy
MedMira Inc., a developer and marketer of rapid diagnostic technology and solutions, today announced its plans to move forward with an outsourced manufacturing strategy. Using an outsourced manufacturing model MedMira can answer the demand..
2009-01-22
Celldex Therapeutics signs license and development agreement with Vaccine Technologies
Celldex Therapeutics, Inc., a biopharmaceutical company engaged in generating a pipeline of candidates to treat cancer and other diseases, has entered into an exclusive license and development agreement with Vaccine Technologies, Inc..
2009-01-06
CellCentric Collaborates on Epigenetic Programme with Takeda
CellCentric, the biotechnology company unlocking epigenetic control mechanisms, has signed an agreement with Takeda, the largest pharmaceutical company in Japan, that covers further validation ..
2009-01-05
Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2
Cylene Pharmaceuticals announced today that it has initiated a Phase I clinical trial of its oral CK2 protein kinase inhibitor, CX-4945, in patients with advanced solid tumors, Castleman's disease, or multiple myeloma. The primary endpoints of the oral dose escalating trial are determination of safety, tolerance and PK properties of CX-4945 and to select the appropriate dose for Phase II trials....
2008-12-16
Cylene initiates Phase II cancer trial
Cylene Pharmaceuticals, a biotech company, has initiated a Phase II clinical trial of quarfloxin in patients with carcinoid/neuroendocrine tumors, which are malignant cancers arising from neural crest cells...
2008-12-08
ThingMagic Releases Astra RFID Reader for European Union; Easy to Deploy, Integrated RFID Reader/Antenna Simplifies Asset Management
ThingMagic, Inc. ( www.thingmagic.com ), a leading developer of radio frequency identification (RFID)technology, today announced that its Astra integrated RFID reader/antenna is available in the European Union. Astra is easy to install, unobtrusive, and available with Power over Ethernet (PoE) and WiFi options...
2008-12-04
Plastic Logic's eReader Display Technology Receives IDTechEx Printed Electronics USA Award for Technical Development
Plastic Logic's breakthrough plastic electronics display technology- the core of its forthcoming new eReader product- has earned the IDTechEx Printed Electronics Award for Technical Development Device . The award was given in recognition of the most significant development of a device..
2008-11-19
CUHK’s Morningside College Celebrates Ground-Breaking
A ground-breaking ceremony was held today (17 December) by The Chinese University of Hong Kong to kick off the construction of Morningside College, one of its newest colleges. Over 100 members of the University and supporters of the College attended the ceremony...
2008-11-18
TENSILICA, INC.;PowerLayer Microsystems Licenses Tensilica's 388VDO Video Engine
Tensilica(R), Inc. announced that PowerLayer Microsystems (PLM), a fabless IC design company headquartered in Beijing, China, licensed the 388VDO video engine, a complete video subsystem that will be designed into integrated circuits for HDTV sets...
2008-11-03
Akamai Completes Acquisition of acerno
Akamai Technologies, Inc. (NASDAQ: AKAM) today announced it has completed its acquisition of acerno, a privately held company based in New York, NY.Akamai announced a definitive agreement on October 21, 2008..
2008-11-02
世界最大靈長類實驗基地落戶呈貢
由香港晨興集團投資、世界規模最大的靈長類研發和安全評價實驗基地——昆明國際生物醫藥發展中心項目昨日正式落戶呈貢新城市。領導仇和、李培山、田雲翔、趙德光、何波以及省市相關部門負責人出席了開業慶典儀式..
2008-10-30
Plastic Logic Earns Award for Innovation from the Plastic Electronics Foundation; "Best Technology Developer" Recognition for the Plastic Logic Reader
Plastic Logic has been recognized by the Plastic Electronics Foundation with one of its first Awards for Innovation.Plastic Logic received the award for 'Best Technology Developer 2008' for the most innovative development in organic electronics - the development of Plastic Logic's innovative new electronic reading device...
2008-10-21
Akamai Introduces Advertising Decision Solutions; Announces Agreement to Acquire acerno
Akamai Technologies, Inc. (NASDAQ: AKAM) and acerno announced today that the two companies have signed a definitive agreement for Akamai to acquire acerno in a merger transaction...
2008-10-05
OriGene Technologies Launches 5,000 Human Antigen Standards for Antibody Validation
OriGene Technologies, Inc. announces it has launched a new product line for antibody validation -- VERIFY(TM) Antigen Standard (http://www.origene.com/lysate/) -- a collection of tagged over-expression cell lysates to be used as Western blot standards. The offering covers 5,000 over-expressed human proteins, each with a built-in C-terminal Myc/DDK tag for easy expression verification and antibody validation...
2008-09-17
Inimex Pharmaceuticals Honored Among This Year's Most Promising Private Technology Ventures in Canada
Inimex Pharmaceuticals was named as an award winner at the second annual "Red Herring Top 50 Canada" awards, September 15 to 17, 2008 at the Red Herring Canada Conference in Mont-Tremblant, Quebec, honoring this year’s most promising...
2008-08-25
三百萬上海人 靠它找路過生活
未來一年，中國手機市場的激戰將會從傳統熟悉的品牌，移轉到iPhone和Google手機之爭。而Google手機更是在具備Google地圖強大功能支援下，為各方看好。為什麼「地圖」會變成炙手可熱？...
2008-08-18
MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced the nomination of MRX- I as its first preclinical development candidate...
2008-08-07
HD Biosciences Announces Completion of Series A Financing
HD Biosciences Inc., a China-based biology contract research organization (CRO) today announced the closing of its Series A financing. The current round was co-led by Morningside Venture and Lilly Asian Ventures and syndicated with Pfizer Venture Investments...
2008-07-30
NYSE Arca Welcomes China Distance Education Holdings Ltd.
NYSE Arca, NYSE Euronext’s fully electronic market for emerging issuers, today welcomed its first Chinese initial public offering, China Distance Education Holdings, a leading provider of online education in China focusing on professional education...
2008-07-17
ThingMagic Closes $9.5 Million in Additional Funding
ThingMagic, a developer of radio frequency identification (RFID) technology, has secured an additional $9.5 million in funding from existing investors including Tudor Ventures, The Exxel Group, Morningside Technology Ventures and .406 Ventures...
2008-06-10
Burnaby company gets money for drug trials; Immune system booster seen as way to help beat superbugs resistant to antibiotics
Imagine your own body mustering its defences to successfully fight off a superbug that is resistant to antibiotics. That's the dream of Burnaby's Inimex Pharmaceuticals, one that has already been proven in animal studies and now has the backing of a major...
2008-06-08
Critical Biologics Commences Clinical Testing of Solinex
Critical Biologics Corporation (CBC) announced the successful enrollment of thefirst four patients in its "first-in-man" clinical trial for Solinex(TM), an intravenous formulation of recombinant human plasma gelsolin (rhu-pGSN). The trial is...
2008-06-02
Inimex Raises US $22 Million in the Fight Against Antibiotic Resistance
Inimex Pharmaceuticals, Inc. is pleased to announce the closing of a US $22 Million Series B venture financing. Leading the round was Morningside Venture Investments Ltd., joined by additional new investors Roche Venture Fund...
2008-05-22
Plastic Logic Start Building New Display Production Site in Dresden
Plastic Logic will start production this fall of 10.7- inch flexible electrophoretic displays at its Dresden, Germany, plant, with annual capacity for a million units, said Tim Von Werne, research and development manager..
2008-04-17
ThingMagic and InnerWireless Integrate Active/Passive RFID for Unified Asset Visibility, Asset Tracking and Document Management
ThingMagic, Inc., the leading developer of radio frequency identification (RFID) technology, and InnerWireless, Inc., the premier provider of converged wireless solutions, today announced a strategic partnership to develop and market...
2008-03-26
中国领先的社区软件与服务提供商“康盛创想（Comsenz）”宣布新一轮融资成功
康盛创想（ComsenzInc.）日前正式披露，公司已于2007年7月完成了第二轮融资。本轮的投资者为晨兴创投（Morningside Ventures），红杉资本（Sequoia Capital）和谷歌（Google）。其中红杉资本中国基金也是康盛创想的首轮投资者...
2008-03-20
Online Bidding Site To Silence Silent Auctions
E-commerce site cMarket expects to host more than 3,000 online fund-raising events for the likes of the United Way and the Muscular Dystrophy Association this year. For many schools and other nonprofit organizations, silent auctions represent a necessary...
2008-02-19
曾培炎在海南調研指出推進結構調整深化改革開放促進海南經濟又好又快發展
國務院副總理曾培炎近日到海南調研，考察了生物、通信、汽車等高技術項目和製造企業，聽取海南省及洋浦經濟開發區工作匯報。他指出，沿海地區要深入貫徹落實科學發展觀，加快轉變經濟發展方式，加大結構調整力度...
2008-02-06
Muscular Dystrophy Association Partners with cMarket to Reach More Donors and Raise More Funds for Medical Research
cMarket today announced that it has been chosen by the Muscular Dystrophy Association (MDA) as its preferred partner for online fundraising auctions. cMarket is the leading online auction platform for schools and nonprofit organizations engaged in...
ThingMagic Partners with Ford Motor Company and DeWALT to Provide First RFID Enabled Trucks
ThingMagic, Inc., the leading developer of radio frequency identification (RFID) technology, today announced a partnership with DEWALT and Ford Motor Company to equip 2009 Ford F-150, F-Series Super Duty pickups and E-Series vans with an embedded...
2008-01-23
New Techniques Tackle Rotator-Cuff Injuries
When it comes to joint injuries, rotator cuffs are the repeat offenders. Surgery can fix the debilitating shoulder problem, but as many as half of patients retear their rotator cuff, often because of overzealous activity or the weakened quality of their...
2008-01-16
Silent Auctions are Fast Losing Ground to Online Fundraising Auctions
Much as "video killed the radio star" with the advent of MTV, the Internet is today's catalyst for the death of the silent fundraising auction, as nonprofits eschew hours of volunteer organizing, venue procurement and hors d'oeuvre selection in favor of the web-based host...
Archived press releases
|
